pilocarpine has been researched along with Atherosclerotic Parkinsonism in 1 studies
Pilocarpine: A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma.
(+)-pilocarpine : The (+)-enantiomer of pilocarpine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Collins-Praino, LE | 1 |
| Paul, NE | 1 |
| Ledgard, F | 1 |
| Podurgiel, SJ | 1 |
| Kovner, R | 1 |
| Baqi, Y | 1 |
| Müller, CE | 1 |
| Senatus, PB | 1 |
| Salamone, JD | 1 |
1 other study available for pilocarpine and Atherosclerotic Parkinsonism
| Article | Year |
|---|---|
Deep brain stimulation of the subthalamic nucleus reverses oral tremor in pharmacological models of parkinsonism: interaction with the effects of adenosine A2A antagonism.
Topics: Adenosine A2 Receptor Antagonists; Animals; Deep Brain Stimulation; Disease Models, Animal; Dopamine | 2013 |